Member Info for BasilAlderman

Yes, 6p to over 60p I recall a couple of months ago. If Val can have a gain like that then Sareum certainly can. Expect the unexpected with aim pharma shares. The pipeline with Sar is huge.

x 10 the current share price is where I think this is initially heading. Thoth's well thought through 28p per share is not looking that outlandish now. Give it a few months and we will be there if Sareum can prove that the science is as good as we believe it to be. Lets hope that Citigate can do better than just the Cambridge local newspaper this time. This is a national business and medical news story. If in the meantime a licencing deal or two drops through the letter box and we also receive the milestone payments for 737 and FLT then who knows how high this could go.....

I can fully understand sellers cashing in but for long term investors in Sareum moving forward this has so much news flow, including now Sareum as an official Covid stock. This is going to climb and climb over the coming weeks and months. We now await news on various licencing agreements and partnerships, the 737Milestone, FLT Milestone etc. I am also of the opinion that Sareum is ripe for a takeover.

The 2.3million buy for £57,101.611 today is another big vote of confidence in Sareum. The volume and the size of many of the buys today bodes well.

Exactly, if Val can go from a penny stock to 60p in a few months then Sareum certainly can. I would also refer you to another small Aim pharma stock, Hemo, which went from 1.8p to over 15p in April on the back of a positive RNS.

A 28p share price fo SAR doesn't look that far fetched now does it. Just over a x 10 increase, which as we have all seen with other small pharma stocks on AIM in 2020 is more than achievable. I'm holding out for the Poundland party (if my nerves can take it!).

Record volume on the cards today. Over 600 trades by 10.30am. It would be good if we could hit 3p today or tomorrow. This would provide a superb launch pad to an end of the week share price of 10p on the back of news.

Logic tends to get thrown out of the window with hot stocks on Aim. Just look at what happened a couple of months ago at ValiRx. 6p to over 60p. If Val can have a gain like that then Sareum certainly can. Those people dismissing something similar with Sareum might need to rethink as share prices on aim, especially pharmaceuticals, have a tendency to rocket irrespective of mcap. Sometimes they just take off and surprise the experts who say it’s “just not possible” etc. Expect the unexpected as talk of this not hitting significant highs could be wide of the mark. As has been pointed out over the last few days here just look at what happened with PYC a couple of years ago rising to over 30p in just a few days from being a penny stock plus Hemo going from 1.8p to 15p in a week earlier this year. And we have all seen what’s happened with NCYT......

As Brighty pointed out last week and based on the fact that Hemo went from an almost identical share price of 1.8p to over 15p in one week following its COVID RNS then I think we could be on for something similar here with SAR. To put this in to some context, we are currently at 1.76p so a 1.8 to 15p rise over a few days = x8. A similar rise to Hemo is therefore clearly possible, if we get positive news.

I'm with RMM. Lets keep this thread going to remind all existing and new Sareum shareholders what can be achieved in one day. 1.3p to 4.2p was achieved by PYC on one day on the back of an RNS back in 2017. If they can do it we certainly can with what is anticipated here. If we get to 2p today or on Monday without news then we could very easily be looking at 5p early next week and higher with news. FOMO is just starting. Have a wonderful afternoon and weekend.

Over 500 shares traded in SAR by 12 Noon. Bodes well for a Friday close of play FOMO session ahead of news next week. Within the next couple of weeks Sareum could have a share price in double figures based on what we have seen with some of the other small aim listed pharmaceutical plcs. Its going to be an interesting afternoon.

I think Brighty might be right about a HEMO style rise of 1.8p to 15p in a week here. Hemo did it on the back of a Covid RNS and we have so much more than Covid news to be announced soon.

As Hemo went from 1.8p to over 15p on a Covid announcement and we have so much more news in the pipeline a similar 800% rise in 7 days on the back of one or more RNS announcements could certainly be achievable for SAR.

800%+ in 1 week for Hemo
1000%+ in a week for PYC
SAR could mirror this type of rise in the coming weeks.

No reason why Sareum cannot do the HEMO 800% gain in one week routine. 1.8p to 15p is certainly achievable.

Hats off to you, Thoth. You have been championing the 28p share price for SAR for quite a while, which now looks a possibility in the coming months. If you are now predicting "poundland" for Sareum then that is very very interestng. You have been right to date. Thanks for your well researched posts.

RMM and Brighty make some interesting points re valuations. RMM's 16p to 20p prediction (see 14th October post) and Brighty's 10p prediction (earlier today) mirror my views. Once the starting pistol has been fired the race will be on to buy Sareum shares.

Having been an investor in Sareum for over a decade it is pretty clear that Tim is not going to change his MO however much we might disapprove of his woeful PR / Comms skills. It is time to relax and watch this unfold as we head to Thoth's 28p (and beyond).

I should clarify that my Hemo style prediction for Sareum of 1.3p to 13p would be over a couple of weeks not in one day! Hemo took a fortnight from mid April to the end of April to achieve it.

A Hemo x10 style gain in the Sareum share price would be about right following a positive Covid grant RNS. i.e. 1.3p to 13p should be possible based on what we have seen share prices in this sector accomplish in 2020. Lets hope Sareum can do the same for us.